Literature DB >> 28940918

Drug therapy adherence and health outcomes in the presence of physician and patient unobserved heterogeneity.

Vincenzo Atella1,2, Federico Belotti1, Domenico Depalo3.   

Abstract

Understanding the role that drug adherence has on health outcomes in everyday clinical practice is central for the policy maker. This is particularly true when patients suffer from asymptomatic chronic conditions (e.g., hypertension, hypercholesterolaemia, and diabetes). By exploiting a unique longitudinal dataset at patient and physician level in Italy, we show that patients and physicians unobserved characteristics play an important role in determining health status, at least as important as drug adherence. Most importantly, we find that both adherence and prescribed treatment regimen effects are highly heterogeneous across physicians, highlighting their crucial role in shaping patients' health status.
Copyright © 2017 John Wiley & Sons, Ltd.

Entities:  

Keywords:  drug adherence; health outcomes; patient heterogeneity; physician heterogeneity

Mesh:

Substances:

Year:  2017        PMID: 28940918     DOI: 10.1002/hec.3570

Source DB:  PubMed          Journal:  Health Econ        ISSN: 1057-9230            Impact factor:   3.046


  3 in total

1.  Physician-Level Cost Control Measures and Regional Variation of Biosimilar Utilization in Germany.

Authors:  Katharina E Blankart; Friederike Arndt
Journal:  Int J Environ Res Public Health       Date:  2020-06-09       Impact factor: 3.390

2.  Adherence during COVID-19: The role of aging and socio-economics status in shaping drug utilization.

Authors:  Cinzia Di Novi; Lucia Leporatti; Rosella Levaggi; Marcello Montefiori
Journal:  J Econ Behav Organ       Date:  2022-10-14

3.  Are patients more adherent to newer drugs?

Authors:  Katharina E Blankart; Frank R Lichtenberg
Journal:  Health Care Manag Sci       Date:  2020-08-08
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.